标题
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-04-24
DOI
10.3389/fphar.2019.00314
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Review article: novel oral-targeted therapies in inflammatory bowel disease
- (2018) J. R. White et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inflammatory bowel disease: new therapies from antisense oligonucleotides
- (2018) Irene Marafini et al. ANNALS OF MEDICINE
- Oligonucleotide-Based Therapies for Inflammatory Bowel Disease
- (2018) Gerolamo Bevivino et al. BIODRUGS
- Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis
- (2018) Raja Atreya et al. DIGESTIVE AND LIVER DISEASE
- Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn’s Disease
- (2018) Brian G. Feagan et al. GASTROENTEROLOGY
- Targeting endothelial ligands: (ICAM-1/Alicaforsen, MAdCAM-1)
- (2018) Walter Reinisch et al. Journal of Crohns & Colitis
- ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detections of complications
- (2018) Christian Maaser et al. Journal of Crohns & Colitis
- Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
- (2017) Gilaad G. Kaplan et al. GASTROENTEROLOGY
- Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice
- (2017) Vanessa Popp et al. GASTROENTEROLOGY
- Novel Insights into the Mechanisms of Gut Homing and Antiadhesion Therapies in Inflammatory Bowel Diseases
- (2017) Sebastian Zundler et al. INFLAMMATORY BOWEL DISEASES
- TLR9 Regulates the NF-κB–NLRP3–IL-1β Pathway Negatively inSalmonella-Induced NKG2D-Mediated Intestinal Inflammation
- (2017) Yan Li et al. JOURNAL OF IMMUNOLOGY
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
- (2017) Siew C Ng et al. LANCET
- FDA-Approved Oligonucleotide Therapies in 2017
- (2017) Cy A. Stein et al. MOLECULAR THERAPY
- Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial
- (2016) Iris Dotan et al. DIGESTIVE DISEASES AND SCIENCES
- Phase 1 Clinical Study of siRNA Targeting Carbohydrate Sulphotransferase 15 in Crohn’s Disease Patients with Active Mucosal Lesions
- (2016) Kenji Suzuki et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- Th9 cells in inflammatory bowel diseases
- (2016) Benno Weigmann et al. Seminars in Immunopathology
- Loss of Response to Anti-TNFs: Definition, Epidemiology and Management
- (2016) Giulia Roda et al. Clinical and Translational Gastroenterology
- Pivotal Role of Carbohydrate Sulfotransferase 15 in Fibrosis and Mucosal Healing in Mouse Colitis
- (2016) Kenji Suzuki et al. PLoS One
- Development of Fibrosis in Acute and Longstanding Ulcerative Colitis
- (2015) Jessica R. de Bruyn et al. Journal of Crohns & Colitis
- Allergen-Induced Asthmatic Responses Modified by a GATA3-Specific DNAzyme
- (2015) Norbert Krug et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn's Disease
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Review article: anti-adhesion therapies for inflammatory bowel disease
- (2014) T. Lobatón et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Biomarkers can predict potential clinical responders to DIMS0150 a toll-like receptor 9 agonist in ulcerative colitis patients
- (2014) Nikolai V Kuznetsov et al. BMC GASTROENTEROLOGY
- T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
- (2014) Mahmoud H. Mosli et al. DRUGS
- IL-9 and its receptor are predominantly involved in the pathogenesis of UC
- (2014) Nancy Nalleweg et al. GUT
- GATA3: a master of many trades in immune regulation
- (2014) Yisong Y. Wan TRENDS IN IMMUNOLOGY
- Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis
- (2013) S. Vegter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Crohn's disease complicated by strictures: a systematic review
- (2013) Florian Rieder et al. GUT
- A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease
- (2012) F. Zorzi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
- (2012) Eugen Musch et al. INFLAMMATORY BOWEL DISEASES
- Phase I Clinical Trial of Smad7 Knockdown Using Antisense Oligonucleotide in Patients With Active Crohn's Disease
- (2012) Giovanni Monteleone et al. MOLECULAR THERAPY
- Biological Therapy for Ulcerative Colitis: What is after Anti-TNF
- (2011) Gionata Fiorino et al. CURRENT DRUG TARGETS
- Regulation of Homeostasis and Inflammation in the Intestine
- (2011) Thomas T. MacDonald et al. GASTROENTEROLOGY
- Colonic treatments and targets: issues and opportunities
- (2009) Emma L. McConnell et al. JOURNAL OF DRUG TARGETING
- Increased mucosal expression of GATA-3 and STAT-4 in pediatric ulcerative colitis
- (2009) Kiyotaka Ohtani et al. PEDIATRICS INTERNATIONAL
- Leukocyte adhesion molecules in animal models of inflammatory bowel disease
- (2008) Jesús Rivera-Nieves et al. INFLAMMATORY BOWEL DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search